Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Esperion Therapeutics
Pharma
Esperion pays $75M for Corstasis and FDA-approved nasal spray
Esperion has paid $75 million upfront to acquire Corstasis Therapeutics and its nasal spray Enbumyst, which was approved by the FDA six months ago.
Kevin Dunleavy
Mar 3, 2026 8:40am
FDA untitled letter skewers Esperion's Nexlizet TV ad
Jan 7, 2026 12:00pm
Esperion campaign sheds light on ‘Lipid Lurkers’ in artery walls
Jul 16, 2024 8:00am
Esperion, Daiichi resolve dispute with $125M settlement
Jan 3, 2024 1:22pm
Takeda, Eisai, GSK and more—Fierce Pharma Asia
Mar 31, 2023 8:27am
Esperion hits Nexletol partner Daiichi with lawsuit
Mar 28, 2023 11:27am
